Amicus Therapeutics
Price & Volume
Stats
See moreOpen | $8.40 |
Previous Close | $8.35 |
Day Range | $8.23-$8.46 |
52W Range | $5.51-$12.65 |
Market Cap | $2.3B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $571.1M |
Revenue Growth (YoY) | 22.1% |
Gross Profit (12 Mos) | $516.1M |
Diluted EPS | -$0.12 |
News
See moreYahoo Finance • 7 days ago
Sector Update: Health Care Stocks Advance Late Afternoon
Yahoo Finance • 7 days ago
Target initiated, Nike upgraded: Wall Street's top analyst calls
Yahoo Finance • 17 days ago
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
Yahoo Finance • 28 days ago
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
About
CEO | Mr. Bradley L. Campbell M.B.A. |
Address | 47 Hulfish Street, Princeton, NJ, United States, 08542 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 499 |
